Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 73620-18-5 | MDL No. : | MFCD00463122 |
Formula : | C10H10O4 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | TVJPCDPSAWVMHA-UHFFFAOYSA-N |
M.W : | 194.18 | Pubchem ID : | 758214 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.2 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 49.22 |
TPSA : | 52.6 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.87 cm/s |
Log Po/w (iLOGP) : | 1.88 |
Log Po/w (XLOGP3) : | 0.87 |
Log Po/w (WLOGP) : | 1.05 |
Log Po/w (MLOGP) : | 0.74 |
Log Po/w (SILICOS-IT) : | 1.77 |
Consensus Log Po/w : | 1.26 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.58 |
Solubility : | 5.12 mg/ml ; 0.0264 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.56 |
Solubility : | 5.37 mg/ml ; 0.0276 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.57 |
Solubility : | 0.521 mg/ml ; 0.00269 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.62 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P280-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H332-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
82% | With potassium carbonate In acetone at 20℃; for 3.5 h; | Methyl 2-(4-formylphenoxy)acetate. To a solution of 4-hydroxybenzaldehyde (3.0 g, 25 mmol) in acetone (61.4 mL), K2C03 (5.43 g, 39.3 mmol) was added and the mixture was stilTed vigorously. Methyibromoacetate (2.8 mL, 29 mmol) was added and the mixture was stirred for 3.5 hrs at room temperature. The reaction mixture was concentrated down under reduced pressure then washed with 11O and extracted with EtOAc. The organic layer was separated, dried over Na2SO4, filtered, and concentrated to give a colorless oil that solidified under vacuum in 82 percent isolated yield. ‘H NMR (400 MHz, CDC13) 3 9.87 (s, 111),7.82 (d, J = 8.8 Hz, 211), 6.98 (d, J = 8.7 Hz, 211), 4.70 (s, 211), 3.79 (s, 3H). ESI-MS (mlz):195.1 [M+Hjt |
82% | With potassium carbonate In acetone at 20℃; for 3.5 h; | To a solution of 4-hydroxybenzaldehyde (3.0 g, 25 mmol) in acetone (61.4 mL), K2CO3 (5.43 g, 39.3 mmol) was added and the mixture was stirred vigorously. Methylbromoacetate (2.8 mL, 29 mmol) was added and the mixture was stirred for 3.5 hrs at room temperature. The reaction mixture was concentrated down under reduced pressure then washed with 0 and extracted with EtOAc. The organic layer was separated, dried over Na2S04, filtered, and concentrated to give a colorless oil that solidified under vacuum in 82 percent isolated yield. H NMR (400 MHz, CDC13) δ 9.87 (s, 1H), |
82% | With potassium carbonate In acetone at 20℃; for 3.5 h; | To a solution of 4-hydroxybenzaldehyde (3.0 g, 25 mmol) in acetone (61.4 mL), K2CO3 (5.43 g, 39.3 mmol) was added and the mixture was stirred vigorously. Methylbromoacetate (2.8 mL, 29 mmol) was added and the mixture was stirred for 3.5 hrs at room temperature. The reaction mixture was concentrated down under reduced pressure then washed with H2O and extracted with EtOAc. The organic layer was separated, dried over Na2SO4, filtered, and concentrated to give a colorless oil that solidified under vacuum in 82 percent isolated yield. 1H NMR (400 MHz, CDCl3) δ 9.87 (s, 1H), 7.82 (d, J = 8.8 Hz, 2H), 6.98 (d, J = 8.7 Hz, 2H), 4.70 (s, 2H), 3.79 (s, 3H). ESI-MS (m/z): 195.1 [M+H]+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
66.1% | With potassium carbonate; sodium iodide In acetone for 12 h; Heating / reflux | Example 68 (4-Formylphenoxy)acetic Acid Methyl Ester (68) To a mixture of 4-hydroxy benzaldehyde (200 grams, 1.64 mol), anhydrous K2CO3 (600 grams, 4.34 mol) and sodium iodide (20 grams, 133 mol) in anhydrous acetone (2500 mL) was added methyl chloro acetate (223 grams, 2.055 mol) and refluxed for 12 hours. Acetone was distilled and water (1800 mL) was added. Crude 68 was extracted in to chloroform, dried over Na2SO4, distilled and purified by column chromatography on silica gel using hexane as eluant to give pure 68 (210 grams, 66.1percent) as a white powder. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
67% | With triphenylphosphine In tetrahydrofuran; diethylazodicarboxylate | EXAMPLE 44 Methyl 2-(4-formylphenoxy)ethanoate A solution of 4-hydroxy benzaldehyde, (1.22 g, 0.01 m), methyl glycolate (0.97 g, 0.01 m), and triphenylphosphine, (3.93 g, 0.015 m), in dry tetrahydrofuran, (50 ml) was stirred with cooling in ice and diethylazodicarboxylate, (2.61 g, 0.015 m), added dropwise. The solution was stirred at room temperature for 0.5 hours, then evaporated in vacuo to dryness. Column chromatography of the residue on silica gel eluding with chloroform yielded 1.30 g (67percent) of the title compound as an oil which crystallized on standing, mp 39°-41° C., νmax (mull) 1750, 1680, 1595, 1575, 1505 cm-1. |
[ 22042-71-3 ]
2-(4-Formylphenoxy)acetic acid
Similarity: 0.98
[ 40359-34-0 ]
Methyl 2-(2-formylphenoxy)acetate
Similarity: 0.96
[ 51264-76-7 ]
2-(2-Ethoxy-4-formylphenoxy)acetic acid
Similarity: 0.94
[ 22042-73-5 ]
4-(2-Hydroxyethoxy)benzaldehyde
Similarity: 0.87
[ 6322-83-4 ]
2-(4-Benzoylphenoxy)acetic acid
Similarity: 0.86
[ 22042-71-3 ]
2-(4-Formylphenoxy)acetic acid
Similarity: 0.98
[ 40359-34-0 ]
Methyl 2-(2-formylphenoxy)acetate
Similarity: 0.96
[ 51264-76-7 ]
2-(2-Ethoxy-4-formylphenoxy)acetic acid
Similarity: 0.94
[ 22042-73-5 ]
4-(2-Hydroxyethoxy)benzaldehyde
Similarity: 0.87
[ 72207-94-4 ]
2-Ethoxy-4-formylphenyl acetate
Similarity: 0.86
[ 22042-71-3 ]
2-(4-Formylphenoxy)acetic acid
Similarity: 0.98
[ 40359-34-0 ]
Methyl 2-(2-formylphenoxy)acetate
Similarity: 0.96
[ 51264-76-7 ]
2-(2-Ethoxy-4-formylphenoxy)acetic acid
Similarity: 0.94
[ 22042-73-5 ]
4-(2-Hydroxyethoxy)benzaldehyde
Similarity: 0.87
[ 6322-83-4 ]
2-(4-Benzoylphenoxy)acetic acid
Similarity: 0.86
[ 40359-34-0 ]
Methyl 2-(2-formylphenoxy)acetate
Similarity: 0.96
[ 72207-94-4 ]
2-Ethoxy-4-formylphenyl acetate
Similarity: 0.86
[ 88530-52-3 ]
Methyl 2-(4-(tert-butyl)phenoxy)acetate
Similarity: 0.84
[ 881-68-5 ]
4-Formyl-2-methoxyphenyl acetate
Similarity: 0.82
[ 56441-97-5 ]
Methyl 4-(benzyloxy)-3-methoxybenzoate
Similarity: 0.81